Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas

被引:57
作者
Haralambieva, E
Pulford, KAF
Lamant, L
Pileri, S
Roncador, G
Gatter, KC
Delsol, G
Mason, DY
机构
[1] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Leukaemia Res Fund Immunodiagnost Unit, Oxford OX3 9DU, England
[2] CHU Purpan, Dept Pathol, Toulouse, France
[3] CHU Purpan, CIGH, CNRS, Toulouse, France
[4] St Orsola Polyclin, Sect Haemolymphopathol Histol, Bologna, Italy
关键词
anaplastic large-cell lymphoma; B-cell markers; ALK protein; (2; 5) translocation; diffuse large B-cell lymphoma;
D O I
10.1046/j.1365-2141.2000.02045.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is controversy in the literature as to whether anaplastic large-cell lymphoma of B-cell phenotype is related to the t(2;5)-positive T- or 'null' cell lymphoma of the same morphology. We report a study of 24 lymphomas with morphological features of anaplastic large-cell lymphoma which expressed one or more B-cell markers and lacked T-lineage markers. Clinical features were more in keeping with large B-cell lymphoma than with classical t(2:5)-positive anaplastic large-cell lymphoma, and immunostaining for anaplastic lymphoma kinase (ALK) protein provided no evidence for the (2;5) translocation (or one of its variants). The staining patterns for CD20 and CD79 were typical of diffuse large B-cell lymphoma, CD30 expression was variable, and most cases (15/22) lacked epithelial membrane antigen (EMA). These findings support the view that 'B-cell anaplastic large-cell lymphoma' is unrelated to t(2:5)-positive (ALK-positive) lymphoma, and that it represents a morphological pattern occasionally encountered among diffuse large B-cell lymphomas. By the same reasoning, most tumours diagnosed as ALK-negative anaplastic large-cell lymphoma of T-cell or null phenotype' probably belong to the spectrum of peripheral T-cell lymphomas.
引用
收藏
页码:584 / 591
页数:8
相关论文
共 43 条
[31]  
Pileri SA, 1997, J PATHOL, V183, P116
[32]   Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 [J].
Pulford, K ;
Lamant, L ;
Morris, SW ;
Butler, LH ;
Wood, KM ;
Stroud, D ;
Delsol, G ;
Mason, DY .
BLOOD, 1997, 89 (04) :1394-1404
[33]   Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma [J].
Pulford, K ;
Falini, B ;
Cordell, J ;
Rosenwald, A ;
Ott, G ;
Müller-Hermelink, HK ;
MacLennan, KA ;
Lamant, L ;
Carbone, A ;
Campo, E ;
Mason, DY .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) :1657-1663
[34]   SUCCESSFUL TREATMENT STRATEGY FOR KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA OF CHILDHOOD - A PROSPECTIVE ANALYSIS OF 62 PATIENTS ENROLLED IN 3 CONSECUTIVE BERLIN-FRANKFURT-MUNSTER GROUP STUDIES [J].
REITER, A ;
SCHRAPPE, M ;
TIEMANN, M ;
PARWARESCH, R ;
ZIMMERMANN, M ;
YAKISAN, E ;
DOPFER, R ;
BUCSKY, P ;
MANN, G ;
GADNER, H ;
RIEHM, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) :899-908
[35]   The clinicopathological features of anaplastic large cell lymphomas expressing p80(NPM/ALK) [J].
Shiota, M ;
Mori, S .
LEUKEMIA & LYMPHOMA, 1996, 23 (1-2) :25-&
[36]   PRIMARY KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL CHARACTERISTICS AND THERAPEUTIC OUTCOME [J].
SHULMAN, LN ;
FRISARD, B ;
ANTIN, JH ;
WHEELER, C ;
PINKUS, G ;
MAGAURAN, N ;
MAUCH, P ;
NOBLES, E ;
MASHAL, R ;
CANELLOS, G ;
TUNG, N ;
KADIN, M .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :937-942
[37]  
Stein H, 1993, Leuk Lymphoma, V10 Suppl, P81, DOI 10.3109/10428199309149117
[38]  
STEIN H, 1985, BLOOD, V66, P848
[39]   Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome [J].
Tilly, H ;
Gaulard, P ;
Lepage, E ;
Dumontet, C ;
Diebold, J ;
Plantier, I ;
Berger, F ;
Symann, M ;
Petrella, T ;
Lederlin, P ;
Briere, J .
BLOOD, 1997, 90 (09) :3727-3734
[40]   Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma [J].
Weisenburger, DD ;
Gordon, BG ;
Vose, JM ;
Bast, MA ;
Chan, WC ;
Greiner, TC ;
Anderson, JR ;
Sanger, WG .
BLOOD, 1996, 87 (09) :3860-3868